American College of Clinical Pharmacy
      Search      Cart
         

Infectious Diseases PRN Focus Session -- Antimicrobial Dosing Dilemmas

Monday, October 09, 2017 from 1:45 PM to 3:15 PM MST at Phoenix Convention Center North Building Street Level: North Ballroom 120D

Available for 1.50 hours of CPE credit
Activity Number: 0217-0000-17-149-L01-P
Activity Type: A Knowledge-Based Activity


Speakers
  • Elias B. Chahine, Pharm.D., FCCP, BCPS-AQ IDModerator: Elias B. Chahine, Pharm.D., FCCP, BCPS-AQ ID
    Associate Professor of Pharmacy Practice, Lloyd L. Gregory School of Pharmacy, Palm Beach Atlantic University, West Palm Beach, Florida
      View Biography

Challenges in Dosing Antimicrobials in Obese and Morbidly Obese Patients
1:45 PM

Speakers
  • Jerod  Nagel, Pharm.D., BCPS-AQ IDSpeaker: Jerod Nagel, Pharm.D., BCPS-AQ ID
    Team Lead, Infectious Diseases, Director Infectious Diseases Residency, Clinical Assistant Instructor, Michigan Medicine, University of Michigan, College of Pharmacy, Ann Arbor, Michigan


Learning Objectives
1. Discuss pharmacokinetic differences in obese and morbidly obese patients.
2. Discuss the efficacy, safety, and cost associated with dosing antimicrobials for obese and morbidly obese patients.
3. Summarize the available literature for dosing vancomycin and beta-lactam antibiotics in obese and morbidly obese patients.
Acute Kidney Injury with Vancomycin Alone and in Combination with Beta-Lactam Antibiotics
2:15 PM

Speakers
  • Jason M. Pogue, Pharm.D., BCPSSpeaker: Jason M. Pogue, Pharm.D., BCPS
    Clinical Pharmacist, Infectious Diseases, Sinai-Grace Hospital, Detroit, Michigan


Learning Objectives
1. Discuss the impact of elevated vancomycin doses and trough concentrations on the development of acute kidney injury
2. Explain the interaction between vancomycin and beta-lactams on the development of acute kidney injury
3. Compare and contrast the rate of acute kidney injury between vancomycin alone and vancomycin plus beta-lactams
Advantages and Disadvantages of Pharmacokinetic Dosing Using Extended- or Continuous-Infusion Antimicrobials
2:45 PM

Speakers
  • Marc H. Scheetz, Pharm.D., M.Sc., BCPSSpeaker: Marc H. Scheetz, Pharm.D., M.Sc., BCPS
    Associate Professor, Midwestern University Chicago College of Pharmacy, Downers Grove, Illinois
      View Biography


Learning Objectives
1. Illustrate the efficacy and safety associated with extended- or continuous-infusion dosing of antibiotics.
2. Describe the costs and institutional logistics in the successful implementation of extended- or continuous-infusion antibiotics.
3. Summarize the recent literature for alternate infusion dosing of beta-lactams and vancomycin.